Recruiting Leukemia Studies in Burlington
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can i...
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
This Phase I/II trial evaluates the safety and preliminary efficacy of DFP-10917 combined with venetoclax in relapsed or refractory acute myeloid leukemia. DFP-10917 is given as a 14-day continuous IV...
About Leukemia Clinical Trials in Burlington
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
There are currently 2 leukemia clinical trials recruiting participants in Burlington, MA. These studies are seeking a combined 169 participants. Research is being sponsored by Johnson & Johnson Enterprise Innovation Inc., Delta-Fly Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Leukemia Clinical Trials in Burlington — FAQ
Are there leukemia clinical trials in Burlington?
Yes, there are 2 leukemia clinical trials currently recruiting in Burlington, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Burlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.
Are clinical trials in Burlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.
What leukemia treatments are being tested?
The 2 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov